USPTO serial 88570495
X PARSOLEX PARTNER SOLUTIONS EXCELLENCE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 18, 2021
- Examiner
- BULLOFF, TOBY ELLEN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with X PARSOLEX PARTNER SOLUTIONS EXCELLENCE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
West Lafayette, IN, US
West Lafayette, IN, US
West Lafayette, IN, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jill J. Chalmers
Jill J. Chalmers BRYAN CAVE LEIGHTON PAISNER LLP90 SOUTH CASCADE AVENUE, SUITE 1300COLORADO SPRINGS, CO 80903UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Market assessment services; consulting services, namely, providing market research and business analysis services in the pharmaceutical, medical and healthcare fields; business consulting and planning services in the field of pharmaceuticals, medicine and healthcare; business consulting and planning services in the field of the commercialization of pharmaceuticals, medicines and healthcare products; business consulting services relating to product distribution, operations management services, logistics, reverse logistics, supply chain, and production systems and distribution solutions; consulting in the fields of sales methods, sales management, and sales improvement; business consultation; business administration consultation services; business operation consultation services; business consulting services in the field of pharmaceutical manufacturing, pharmaceutical packaging, and distribution; business consulting in the pharmaceutical products, medical and healthcare industries; business consulting, business management, business advisory services; marketing consulting services in the field of pharmaceuticals, medicine and healthcare; business marketing consulting services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; branding and marketing services for others in the field of pharmaceutical, medical, and healthcare industries; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; advertising of custom services for pharmaceutical formulation design, design of processes to transform inorganic and organic substances, scale-up of pharmaceutical manufacturing processes, pharmaceutical technology transfer, manufacture of pharmaceuticals, and chemical and physical evaluation of pharmaceuticals for others; distributorship services of pharmaceutical and medical products for others; commercialization of pharmaceuticals and medical products for others | ACTIVE | Oct 28, 2019 |
| 045 | Consulting services in the field of regulatory compliance in the pharmaceutical, medical and healthcare industries; regulatory services for others, namely, tracking and monitoring regulatory requirements in the field of the pharmaceutical, medical, and healthcare industries for regulatory compliance purposes | ACTIVE | Oct 28, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Parsolex GMP Center, Inc.
- Other trademarks owned by Parsolex GMP Center, Inc.
- Other trademarks owned by Parsolex GMP Center, Inc.
- Other trademarks in Class 035
- Other trademarks in Class 045
- Similar marks named X PARSOLEX PARTNER SOLUTIONS EXCELLENCE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 18, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 18, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 16, 2021 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Apr 15, 2021 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Apr 2, 2021 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Apr 1, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 17, 2021 | IUAF | USE AMENDMENT FILED | — |
| Mar 17, 2021 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Sep 22, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 28, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 28, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 8, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 24, 2020 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 16, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 16, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 16, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 16, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 16, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 10, 2020 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 5, 2020 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Apr 22, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 22, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 22, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 22, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 22, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 16, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 16, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 15, 2020 | ALIE | ASSIGNED TO LIE | — |
| Apr 8, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 31, 2019 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 31, 2019 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 31, 2019 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 16, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 27, 2019 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 24, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 10, 2019 | NWAP | NEW APPLICATION ENTERED | — |